Back Login for AI Analysis

    PRME (STOCKS)

    Prime Medicine, Inc. Common Stock

    $3.280000
    -0.170000 (-4.93%)
    Prev close: $3.450000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Allan Jacob Reine
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $598.39M
    Employees
    214
    P/E (TTM)
    -2.25
    P/B (TTM)
    3.84
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State

    Analyst Recommendations
    5
    Strong Buy
    7
    Buy
    5
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Sep 2025 (Q3)
    $-0.32 $-0.26 -0.0619 -23.98%
    Jun 2025 (Q2)
    $-0.41 $-0.37 -0.0391 -10.54%
    Mar 2025 (Q1)
    $-0.40 $-0.33 -0.0735 -22.51%
    Dec 2024 (Q4)
    $-0.31 $-0.40 +0.0898 +22.46%
    Financial Statements
    TTM (Sep 2025)
    Revenues $5.98M
    Benefits Costs and Expenses $0.00
    Costs And Expenses $209.94M
    Nonoperating Income/Loss $6.63M
    Operating Expenses $209.94M
    Research and Development $160.03M
    Other Operating Expenses $49.91M
    Operating Income/Loss -$203.96M
    Income/Loss From Continuing Operations After Tax -$197.34M
    Income/Loss From Continuing Operations Before Tax -$101.07M
    Net Income/Loss -$197.34M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$197.34M
    Net Income/Loss Available To Common Stockholders, Basic -$197.34M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$1.44
    Diluted Earnings Per Share -$1.44
    Basic Average Shares 424,681,556
    Diluted Average Shares 424,681,556
    Assets $385.01M
    Current Assets $231.41M
    Cash $213.30M
    Prepaid Expenses $2.49M
    Other Current Assets $15.61M
    Noncurrent Assets $153.61M
    Fixed Assets $22.05M
    Other Non-current Assets $131.56M
    Liabilities $223.19M
    Current Liabilities $35.02M
    Accounts Payable $9.35M
    Wages $6.76M
    Other Current Liabilities $18.91M
    Noncurrent Liabilities $188.17M
    Equity $161.82M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $161.82M
    Liabilities And Equity $385.01M
    Net Cash Flow From Operating Activities -$109.06M
    Net Cash Flow From Operating Activities, Continuing -$109.06M
    Net Cash Flow From Investing Activities -$88.84M
    Net Cash Flow From Investing Activities, Continuing -$88.84M
    Net Cash Flow From Financing Activities $150.95M
    Net Cash Flow From Financing Activities, Continuing $150.95M
    Net Cash Flow -$46.95M
    Net Cash Flow, Continuing -$46.95M
    Comprehensive Income/Loss -$197.32M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$197.33M
    Other Comprehensive Income/Loss -$92.84M